Ignite Creation Date:
2025-12-26 @ 12:14 PM
Ignite Modification Date:
2025-12-26 @ 12:14 PM
Study NCT ID:
NCT06207500
Status:
TERMINATED
Last Update Posted:
2024-01-17
First Post:
2023-12-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluation of Pharmacist-led Medication Reconciliation Service Benefits in Hospitalised Medical Patients
Sponsor:
The University Clinic of Pulmonary and Allergic Diseases Golnik
Organization:
Study Overview
Official Title:
Impact of Routine Pharmacist-led Medication Reconciliation on Medication Discrepancies and Post-hospital Healthcare Utilisation
Status:
TERMINATED
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Due to COVID 19 declaration in Slovenia for the second time and subsequent reorganization of intervention ward
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Background:
Transitions of care often lead to medication errors and unnecessary healthcare utilisation. It has been repeatedly shown that medication reconciliation can at least partially reduce this risk.
Objective:
The aim of this prospective pragmatic trial was to evaluate the effectiveness of pharmacist-led medication reconciliation offered to medical patients as part of routine clinical practise.
The main questions to be answered were:
* the effectiveness of pharmacist-led medication reconciliation on medication discrepancies at discharge and 30 days after discharge
* the effectiveness of pharmacist-led medication reconciliation on healthcare utilisation within 30 days after discharge.
Participants in the intervention group were offered the following:
* medication reconciliation on admission
* medication reconciliation on discharge, coupled with patient counselling, provided by clinical pharmacists.
Participants in the control group were offered standard care.
Transitions of care often lead to medication errors and unnecessary healthcare utilisation. It has been repeatedly shown that medication reconciliation can at least partially reduce this risk.
Objective:
The aim of this prospective pragmatic trial was to evaluate the effectiveness of pharmacist-led medication reconciliation offered to medical patients as part of routine clinical practise.
The main questions to be answered were:
* the effectiveness of pharmacist-led medication reconciliation on medication discrepancies at discharge and 30 days after discharge
* the effectiveness of pharmacist-led medication reconciliation on healthcare utilisation within 30 days after discharge.
Participants in the intervention group were offered the following:
* medication reconciliation on admission
* medication reconciliation on discharge, coupled with patient counselling, provided by clinical pharmacists.
Participants in the control group were offered standard care.
Detailed Description:
Design: pragmatic, prospective, controlled clinical trial
Setting: Five general medical wards at the University Clinic of Respiratory and Allergic Diseases in Slovenia:
* one intervention ward with a routine pharmacist-led medication reconciliation service
* four control wards
Data collection:
* Data collection and outcome assessment were performed by research pharmacists who were clinical pharmacists or final year clinical pharmacy residents not involved in the treatment of the included patients.
* Data for the assessment of medication errors at discharge were obtained from the patients' medical records and the study documentation.
* The reason for the patient's hospitalisation was obtained from the discharge letter and divided into acute or planned admissions. The main diagnosis was the reason for admission, while all other patient diagnoses listed were used to assess comorbidity.
* Patient comorbidity was assessed using the Charlson Comorbidity Index
* For patients in the control group the BPMH was collected in the same way as in the intervention group. However, it was only used for study purposes and was not documented in the patients' medical records
* Data on healthcare utilisation and medication discrepancies after hospital discharge were collected through patients or caregivers' phone interview.
Setting: Five general medical wards at the University Clinic of Respiratory and Allergic Diseases in Slovenia:
* one intervention ward with a routine pharmacist-led medication reconciliation service
* four control wards
Data collection:
* Data collection and outcome assessment were performed by research pharmacists who were clinical pharmacists or final year clinical pharmacy residents not involved in the treatment of the included patients.
* Data for the assessment of medication errors at discharge were obtained from the patients' medical records and the study documentation.
* The reason for the patient's hospitalisation was obtained from the discharge letter and divided into acute or planned admissions. The main diagnosis was the reason for admission, while all other patient diagnoses listed were used to assess comorbidity.
* Patient comorbidity was assessed using the Charlson Comorbidity Index
* For patients in the control group the BPMH was collected in the same way as in the intervention group. However, it was only used for study purposes and was not documented in the patients' medical records
* Data on healthcare utilisation and medication discrepancies after hospital discharge were collected through patients or caregivers' phone interview.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: